|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.000 HKD | +9.29% |
|
+12.99% | -42.86% |
Company Valuation: Kaisa Health Group
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 690.8 | 393.3 | 352.9 | 171.4 | 121 | 352.9 |
| Change | - | -43.07% | -10.26% | -51.43% | -29.41% | 191.67% |
| Enterprise Value (EV) 1 | 518.6 | 166.3 | 211.4 | 15.35 | -17.95 | 256.8 |
| Change | - | -67.93% | 27.1% | -92.74% | -216.9% | 1,530.8% |
| P/E | -17.3x | 167x | -2.86x | 23x | -2.61x | -7.56x |
| PBR | 1.09x | 0.6x | 0.73x | 0.35x | 0.28x | 0.87x |
| PEG | - | -2x | 0x | -0x | 0x | -10.85x |
| Capitalization / Revenue | 3.76x | 1.88x | 1.84x | 0.92x | 0.65x | 2.54x |
| EV / Revenue | 2.82x | 0.79x | 1.1x | 0.08x | -0.1x | 1.85x |
| EV / EBITDA | -17.7x | -2.74x | -4.22x | -0.41x | 1.15x | -5.32x |
| EV / EBIT | -12.3x | -2.13x | -2.93x | -0.32x | 0.77x | -4.64x |
| EV / FCF | -12.9x | -2.32x | -28.3x | -0.21x | 25.2x | -6.62x |
| FCF Yield | -7.77% | -43% | -3.54% | -472% | 3.96% | -15.1% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.395 | 0.0234 | -1.225 | 0.0741 | -0.4597 | -0.4629 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 183.8 | 209.6 | 191.5 | 185.9 | 185.4 | 139.1 |
| EBITDA 1 | -29.3 | -60.68 | -50.07 | -37.34 | -15.56 | -48.31 |
| EBIT 1 | -42.21 | -77.93 | -72.24 | -47.86 | -23.23 | -55.4 |
| Net income 1 | -39.69 | 2.359 | -123.3 | 7.468 | -46.36 | -46.68 |
| Net Debt 1 | -172.2 | -227 | -141.6 | -156.1 | -139 | -96.14 |
| Reference price 2 | 6.850 | 3.900 | 3.500 | 1.700 | 1.200 | 3.500 |
| Nbr of stocks (in thousands) | 100,843 | 100,843 | 100,843 | 100,843 | 100,843 | 100,843 |
| Announcement Date | 4/30/21 | 4/29/22 | 4/28/23 | 4/29/24 | 4/28/25 | 4/28/26 |
1HKD in Million2HKD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 23.52M | |
| 33.6x | 5.84x | 18.95x | 1.04% | 20.05B | |
| 23.11x | 3.82x | 13.82x | 2.03% | 17.09B | |
| 34.16x | 3.46x | 16.3x | 2.71% | 5.8B | |
| 19.84x | 2.56x | 9.9x | 1.88% | 4.2B | |
| 59.91x | 3.98x | 30.59x | 0.71% | 2B | |
| 19.28x | 2.25x | 10.96x | -.--% | 1.9B | |
| 20.2x | 4.06x | 12.2x | 0.98% | 1.15B | |
| -22.92x | - | - | - | 534M | |
| Average | 23.40x | 3.71x | 16.10x | 1.33% | 5.86B | |
| Weighted average by Cap. | 28.79x | 4.41x | 16.25x | 1.56% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 876 Stock
- Valuation Kaisa Health Group
Select your edition
All financial news and data tailored to specific country editions
